We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ETON market cap is 402.8M. The company's latest EPS is USD -0.1426 and P/E is -105.33.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 7.97M | 9.07M | 10.32M | 11.65M | 17.28M |
| Operating Income | -800k | -2.94M | 509k | 629k | -470k |
| Net Income | -811k | -3.04M | 627k | -598k | -1.57M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 39k | 21.83M | 21.25M | 31.64M | 39.01M |
| Operating Income | -27.11M | -1.5M | -8.26M | -1.19M | -2.6M |
| Net Income | -27.97M | -1.96M | -9.02M | -936k | -3.82M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 30.79M | 31.82M | 35.84M | 76.12M | 84.03M |
| Total Liabilities | 15.3M | 18.36M | 19.86M | 51.7M | 59.58M |
| Total Equity | 15.49M | 13.46M | 15.98M | 24.43M | 24.45M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 26.32M | 27.47M | 25.03M | 31.74M | 76.12M |
| Total Liabilities | 10.66M | 9.84M | 11.95M | 16.26M | 51.7M |
| Total Equity | 15.66M | 17.63M | 13.08M | 15.48M | 24.43M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.47M | -1.22M | 1.73M | 969k | 2.09M |
| Investing | -1.88M | -1.88M | -1.88M | -40.01M | N/A |
| Financing | -378k | -594k | -979k | 32.59M | 394k |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.35M | -4.51M | 4.82M | 6.82M | 969k |
| Investing | -50k | -2.56M | -2.79M | -775k | -40.01M |
| Financing | 31.63M | 391k | -134k | -957k | 32.59M |
| Market Cap | 402.8M |
| Price to Earnings Ratio | -105.33 |
| Price to Sales Ratio | 10.33 |
| Price to Cash Ratio | 26.97 |
| Price to Book Ratio | 16.49 |
| Dividend Yield | - |
| Shares Outstanding | 26.82M |
| Average Volume (1 week) | 578.14k |
| Average Volume (1 Month) | 664.92k |
| 52 Week Change | 317.22% |
| 52 Week High | 21.48 |
| 52 Week Low | 3.2519 |
| Spread (Intraday) | 1.56 (9.71%) |
| Company Name | Eton Pharmaceuticals Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.etonpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
